Cargando…

Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report

Myotonic dystrophy type 1 is a rare genetic disorder that mainly affects the musculoskeletal system; However, it may cause several complications in other body systems representing challenges for health care providers. PATIENT CONCERNS: We present the case of a patient with a history of previously di...

Descripción completa

Detalles Bibliográficos
Autores principales: Londoño-Tobón, Luisa, García, Cesar Augusto Ortiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524931/
https://www.ncbi.nlm.nih.gov/pubmed/36181121
http://dx.doi.org/10.1097/MD.0000000000030518
_version_ 1784800597801697280
author Londoño-Tobón, Luisa
García, Cesar Augusto Ortiz
author_facet Londoño-Tobón, Luisa
García, Cesar Augusto Ortiz
author_sort Londoño-Tobón, Luisa
collection PubMed
description Myotonic dystrophy type 1 is a rare genetic disorder that mainly affects the musculoskeletal system; However, it may cause several complications in other body systems representing challenges for health care providers. PATIENT CONCERNS: We present the case of a patient with a history of previously diagnosed type 1 myotonic dystrophy who presented to the emergency department with cough dyspnea, and thoracic pain. DIAGNOSIS: Differential diagnoses included pulmonary embolism with a moderate probability according to the Wells score, acute coronary syndrome, acute heart failure, and pneumonia. Diagnostic workup involved chest radiography, EKG, and a CTPA which revealed pneumonia, posteriorly the patient presented de novo atrial fibrillation. INTERVENTIONS: The patient was successfully treated with empiric antibiotic therapy and amiodarone, respiratory and physical therapy. OUTCOMES: The patient was discharged on day 34, however oxygen weaning was not possible. CONCLUSION: Treatment of MD1 patients is challenging due to the various mechanisms of the disease; patients with new-onset deterioration should be screened for the most common complications such as cardio-respiratory events. The authors suggest pneumonia as a risk factor for basal respiratory function deterioration and a contributing factor for triggering cardiac events for further research in prospective studies.
format Online
Article
Text
id pubmed-9524931
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95249312022-10-03 Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report Londoño-Tobón, Luisa García, Cesar Augusto Ortiz Medicine (Baltimore) Research Article Myotonic dystrophy type 1 is a rare genetic disorder that mainly affects the musculoskeletal system; However, it may cause several complications in other body systems representing challenges for health care providers. PATIENT CONCERNS: We present the case of a patient with a history of previously diagnosed type 1 myotonic dystrophy who presented to the emergency department with cough dyspnea, and thoracic pain. DIAGNOSIS: Differential diagnoses included pulmonary embolism with a moderate probability according to the Wells score, acute coronary syndrome, acute heart failure, and pneumonia. Diagnostic workup involved chest radiography, EKG, and a CTPA which revealed pneumonia, posteriorly the patient presented de novo atrial fibrillation. INTERVENTIONS: The patient was successfully treated with empiric antibiotic therapy and amiodarone, respiratory and physical therapy. OUTCOMES: The patient was discharged on day 34, however oxygen weaning was not possible. CONCLUSION: Treatment of MD1 patients is challenging due to the various mechanisms of the disease; patients with new-onset deterioration should be screened for the most common complications such as cardio-respiratory events. The authors suggest pneumonia as a risk factor for basal respiratory function deterioration and a contributing factor for triggering cardiac events for further research in prospective studies. Lippincott Williams & Wilkins 2022-09-30 /pmc/articles/PMC9524931/ /pubmed/36181121 http://dx.doi.org/10.1097/MD.0000000000030518 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Londoño-Tobón, Luisa
García, Cesar Augusto Ortiz
Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report
title Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report
title_full Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report
title_fullStr Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report
title_full_unstemmed Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report
title_short Pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: A case report
title_sort pneumonia and de novo atrial fibrillation in a patient with myotonic dystrophy type 1: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524931/
https://www.ncbi.nlm.nih.gov/pubmed/36181121
http://dx.doi.org/10.1097/MD.0000000000030518
work_keys_str_mv AT londonotobonluisa pneumoniaanddenovoatrialfibrillationinapatientwithmyotonicdystrophytype1acasereport
AT garciacesaraugustoortiz pneumoniaanddenovoatrialfibrillationinapatientwithmyotonicdystrophytype1acasereport